PGRCX
Price
$56.62
Change
-$0.04 (-0.07%)
Updated
Sep 16 closing price
Net Assets
1.04B
RNPAX
Price
$67.20
Change
+$0.10 (+0.15%)
Updated
Sep 16 closing price
Net Assets
162.63B
Interact to see
Advertisement

PGRCX vs RNPAX

Header iconPGRCX vs RNPAX Comparison
Open Charts PGRCX vs RNPAXBanner chart's image
BNY Mellon Worldwide Growth C
Price$56.62
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets1.04B
American Funds New Perspective R1
Price$67.20
Change+$0.10 (+0.15%)
VolumeN/A
Net Assets162.63B
PGRCX vs RNPAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PGRCX vs. RNPAX commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGRCX is a Buy and RNPAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPAX has more cash in the bank: 163B vs. PGRCX (1.04B). PGRCX (0.00) and RNPAX (0.00) have matching dividends . PGRCX was incepted earlier than RNPAX: PGRCX (30 years) vs RNPAX (23 years). PGRCX (1.89) is less costly to investors than RNPAX (1.49). RNPAX is a more actively managed with annual turnover of: 24.00 vs. PGRCX (13.83). RNPAX has a lower initial minimum investment than PGRCX: RNPAX (250) vs PGRCX (1000). RNPAX annual gain was more profitable for investors over the last year : 13.84 vs. PGRCX (-4.47). RNPAX return over 5 years is better than : 32.89 vs. PGRCX (11.20).
PGRCXRNPAXPGRCX / RNPAX
Total Expense Ratio1.891.49127%
Annual Report Gross Expense Ratio1.891.49127%
Fund Existence30 years23 years-
Gain YTD10.40517.83358%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.04B163B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year-4.4713.84-32%
Returns for 3 years17.4448.4236%
Returns for 5 years11.2032.8934%
Returns for 10 years24.5991.5727%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QDEL29.530.61
+2.11%
QuidelOrtho Corp
CBUS1.380.01
+0.73%
Cibus
CMCO14.830.04
+0.27%
Columbus McKinnon Corp
SLXN3.53-0.08
-2.22%
Silexion Therapeutics Corp
CDE16.27-0.66
-3.90%
Coeur Mining